• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠心脏中的高亲和力醛固酮结合位点(I型受体)。

High affinity aldosterone binding sites (type I receptors) in rat heart.

作者信息

Pearce P, Funder J W

机构信息

Medical Research Centre, Prince Henry's Hospital, Melbourne, Victoria, Australia.

出版信息

Clin Exp Pharmacol Physiol. 1987 Nov-Dec;14(11-12):859-66. doi: 10.1111/j.1440-1681.1987.tb02422.x.

DOI:10.1111/j.1440-1681.1987.tb02422.x
PMID:2966024
Abstract
  1. The use of the receptor stabilizing agent sodium molybdate, and of RU26988 to exclude [3H]-aldosterone binding from Type II glucocorticoid receptors, has enabled the characterization of high affinity Type I aldosterone binding sites in rat atrial and ventricular cytosols. 2. In adult male and female rats the affinity of binding (Kd 4 degrees C) is approximately 1-2 nmol/l for both atria and ventricles; specificity of binding is similar to that for Type I sites in classical aldosterone target tissues (aldosterone = corticosterone much greater than dexamethasone). 3. Levels of atrial Type I sites are higher than the corresponding levels in ventricle in both males and females, whereas for Type II (classical glucocorticoid) receptors the reverse is the case; levels of both Type I and Type II sites fall over the age range examined (40 days-6 months). 4. The physiological function(s) of cardiac Type I sites, and their in vivo mineralocorticoid or glucocorticoid selectivity, remain to be explored.
摘要
  1. 使用受体稳定剂钼酸钠以及RU26988来排除II型糖皮质激素受体对[3H]-醛固酮的结合,从而能够对大鼠心房和心室胞质溶胶中的高亲和力I型醛固酮结合位点进行表征。2. 在成年雄性和雌性大鼠中,心房和心室的结合亲和力(4℃时的解离常数)约为1-2 nmol/l;结合特异性与经典醛固酮靶组织中I型位点的特异性相似(醛固酮=皮质酮远大于地塞米松)。3. 雄性和雌性大鼠心房I型位点的水平均高于心室中的相应水平,而对于II型(经典糖皮质激素)受体则相反;在研究的年龄范围内(40天至6个月),I型和II型位点的水平均下降。4. 心脏I型位点的生理功能及其体内盐皮质激素或糖皮质激素的选择性仍有待探索。

相似文献

1
High affinity aldosterone binding sites (type I receptors) in rat heart.大鼠心脏中的高亲和力醛固酮结合位点(I型受体)。
Clin Exp Pharmacol Physiol. 1987 Nov-Dec;14(11-12):859-66. doi: 10.1111/j.1440-1681.1987.tb02422.x.
2
High-affinity aldosterone binding in rat liver--a re-evaluation.大鼠肝脏中高亲和力醛固酮结合——重新评估
Clin Exp Pharmacol Physiol. 1987 Jan;14(1):39-45. doi: 10.1111/j.1440-1681.1987.tb00955.x.
3
Characterization of rat brain aldosterone receptors reveals high affinity for corticosterone.大鼠脑醛固酮受体的特性揭示了其对皮质酮具有高亲和力。
Endocrinology. 1983 Dec;113(6):2043-51. doi: 10.1210/endo-113-6-2043.
4
Equivalent affinity of aldosterone and corticosterone for type I receptors in kidney and hippocampus: direct binding studies.醛固酮和皮质酮对肾脏和海马体中I型受体的亲和力相当:直接结合研究
J Steroid Biochem. 1987 Dec;28(6):737-42. doi: 10.1016/0022-4731(87)90406-7.
5
RU-26988--a new tool for the study of the mineralocorticoid receptor.RU-26988——一种用于研究盐皮质激素受体的新工具。
Endocrinology. 1983 Sep;113(3):1004-9. doi: 10.1210/endo-113-3-1004.
6
Detection of corticosteroid type I binding sites in heart.
Mol Cell Endocrinol. 1988 Apr;56(3):191-8. doi: 10.1016/0303-7207(88)90060-3.
7
High affinity (type 1) aldosterone-binding sites in rat epididymis.
Endocrinology. 1986 May;118(5):2072-5. doi: 10.1210/endo-118-5-2072.
8
Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity.肾脏盐皮质激素受体和海马皮质酮结合物质具有相同的内在类固醇特异性。
Proc Natl Acad Sci U S A. 1983 Oct;80(19):6056-60. doi: 10.1073/pnas.80.19.6056.
9
Sex differences in the distribution and regulation of glucocorticoid receptors in cardiac tissues of rats.大鼠心脏组织中糖皮质激素受体分布与调节的性别差异。
J Mol Cell Cardiol. 1986 Mar;18(3):331-3. doi: 10.1016/s0022-2828(86)80415-1.
10
Activation of cytosol aldosterone receptors in rat kidney.
Arch Int Physiol Biochim. 1985 May;93(1):49-58. doi: 10.3109/13813458509104515.

引用本文的文献

1
Anti-Proliferative and Anti-Migratory Activity of Licorice Extract and Glycyrrhetinic Acid on Papillary Thyroid Cancer Cell Cultures.甘草提取物及甘草次酸对甲状腺乳头癌细胞增殖和迁移的抑制作用。
Int J Mol Sci. 2024 Oct 8;25(19):10800. doi: 10.3390/ijms251910800.
2
Finerenone: From the Mechanism of Action to Clinical Use in Kidney Disease.非奈利酮:从作用机制到在肾脏疾病中的临床应用
Pharmaceuticals (Basel). 2024 Mar 26;17(4):418. doi: 10.3390/ph17040418.
3
First Evidence of Mineralocorticoid Receptor Gene and Protein Expression in Rat and Human Thyroid Tissues and Cell Cultures.
大鼠和人甲状腺组织和细胞培养中醛固酮受体基因和蛋白表达的初步证据。
Int J Mol Sci. 2024 Jan 6;25(2):754. doi: 10.3390/ijms25020754.
4
Nonsteroidal Mineralocorticoid Receptor Antagonist Eliciting Cardiorenal Protection Is a New Option for Patients with Chronic Kidney Disease.非甾体类盐皮质激素受体拮抗剂引发的心肾保护作用是慢性肾脏病患者的新选择。
Kidney Dis (Basel). 2022 Nov 14;9(1):12-25. doi: 10.1159/000528066. eCollection 2023 Jan.
5
Identifying new cellular mechanisms of mineralocorticoid receptor activation in the heart.鉴定心脏中醛固酮受体激活的新细胞机制。
J Hum Hypertens. 2021 Feb;35(2):124-130. doi: 10.1038/s41371-020-0386-5. Epub 2020 Jul 30.
6
Mineralocorticoid receptor antagonists attenuate exaggerated exercise pressor reflex responses in hypertensive rats.盐皮质激素受体拮抗剂可减弱高血压大鼠过度的运动升压反射反应。
Am J Physiol Heart Circ Physiol. 2017 Oct 1;313(4):H788-H794. doi: 10.1152/ajpheart.00155.2017. Epub 2017 Jul 21.
7
30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor antagonists: 60 years of research and development.盐皮质激素受体的30年:盐皮质激素受体拮抗剂:60年的研发历程
J Endocrinol. 2017 Jul;234(1):T125-T140. doi: 10.1530/JOE-16-0600.
8
Regulation of aldosterone secretion by mineralocorticoid receptor-mediated signaling.盐皮质激素受体介导的信号传导对醛固酮分泌的调节。
J Endocrinol. 2017 Mar;232(3):525-534. doi: 10.1530/JOE-16-0452. Epub 2017 Jan 17.
9
Aldosterone Disrupts the Intercellular Flow of Glucose in Cardiac Muscle.醛固酮破坏心肌细胞间的葡萄糖流动。
Front Endocrinol (Lausanne). 2015 Dec 11;6:185. doi: 10.3389/fendo.2015.00185. eCollection 2015.
10
Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine.盐皮质激素受体拮抗剂:在心血管医学中的新作用
Integr Blood Press Control. 2013 Oct 4;6:129-38. doi: 10.2147/IBPC.S13783.